BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Opexa Therapeutics 

2635 N. Crescent Ridge Drive

The Woodlands  Texas  77381  U.S.A.
Phone: 281-272-9331 Fax: 281-272-1088


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Cell Therapy





 Company News
Opexa Therapeutics (OPXA) Supports National Multiple Sclerosis Society And Walk MS 10/22/2014 10:10:02 AM
Opexa Therapeutics (OPXA) To Present At Cleveland Clinic’s 12th Annual Medical Innovation Summit 10/20/2014 9:42:48 AM
Opexa Therapeutics (OPXA) Announces Analyst And Investor Event 10/3/2014 8:02:10 AM
Opexa Therapeutics (OPXA) Announces Proposed Public Offering Of Common Stock 9/16/2014 1:02:15 PM
Opexa Therapeutics (OPXA) Announces Termination of Public Offering of Common Stock 9/16/2014 7:33:10 AM
Opexa Therapeutics (OPXA) To Target Rare Disease Neuromyelitis Optica (NMO) As next Development Program 9/8/2014 11:28:19 AM
Opexa Therapeutics (OPXA) To Present At September Conferences 9/2/2014 12:55:26 PM
Opexa Therapeutics (OPXA) Reports Second Quarter 2014 Financial Results And Provides Corporate Update 8/15/2014 8:29:14 AM
Opexa Therapeutics (OPXA) Joins Russell Microcap Index 6/30/2014 8:33:42 AM
Opexa Therapeutics (OPXA) Reaches Enrollment Target In Phase IIb Trial Of Personalized Immunotherapy For Secondary Progressive Multiple Sclerosis 5/13/2014 8:10:04 AM
12345678910...